Cargando…

Anticoagulation in pediatric cancer–associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr

Anticoagulant treatment of pediatric cancer–associated venous thromboembolism (VTE) has not been prospectively evaluated. Management of anticoagulation for cancer-associated VTE is often challenged by drug interactions and treatment interruptions. A total of 56 of the 500 children (11.2%) with VTE w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palumbo, Joseph S., Lensing, Anthonie W.A., Brandão, Leonardo R., Hooimeijer, Hélène L., Kenet, Gili, van Ommen, Heleen, Pap, Akos F., Majumder, Madhurima, Kubitza, Dagmar, Thelen, Kirstin, Willmann, Stefan, Prins, Martin H., Monagle, Paul, Male, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2022
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641171/ https://www.ncbi.nlm.nih.gov/pubmed/36006613 http://dx.doi.org/10.1182/bloodadvances.2022008160

Ejemplares similares

Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study
por: Kubitza, Dagmar, et al.
Publicado: (2018)

Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study
por: Lensing, Anthonie W. A., et al.
Publicado: (2018)

Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
por: Willmann, Stefan, et al.
Publicado: (2018)

Use of Prestudy Heparin Did Not Influence the Efficacy and Safety of Rivaroxaban in Patients Treated for Symptomatic Venous Thromboem‐bolism in the EINSTEIN DVT and EINSTEIN PE Studies
por: Prandoni, Paolo, et al.
Publicado: (2015)

Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment
por: Bauersachs, Rupert M, et al.
Publicado: (2014)

Treatment of Pulmonary Embolism With Rivaroxaban: Outcomes by Simplified Pulmonary Embolism Severity Index Score from a Post Hoc Analysis of the EINSTEIN PE Study
por: Fermann, Gregory J, et al.
Publicado: (2015)

Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies
por: Wang, Yuqi, et al.
Publicado: (2013)

Sex‐specific differences in clot resolution 3 weeks after acute pulmonary embolism managed with anticoagulants—A substudy of the EINSTEIN‐PE study
por: Wiegers, Hanke M. G., et al.
Publicado: (2021)

Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism
por: Prins, Martin H, et al.
Publicado: (2013)

Clinical presentation and therapeutic management of venous thrombosis in young children: a retrospective analysis
por: Chan, Anthony, et al.
Publicado: (2018)

Population pharmacokinetic analysis of rivaroxaban in children and comparison to prospective physiologically‐based pharmacokinetic predictions
por: Willmann, Stefan, et al.
Publicado: (2021)

Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program
por: Yamada, Norikazu, et al.
Publicado: (2015)

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
por: Prins, Martin H, et al.
Publicado: (2013)

Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy
por: Wells, Philip S, et al.
Publicado: (2014)

Erratum to: ‘Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program’
por: Yamada, Norikazu, et al.
Publicado: (2016)

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin
por: Boonyawat, Kochawan, et al.
Publicado: (2021)

Elastic compression stockings for prevention of the post-thrombotic syndrome in patients with and without residual vein thrombosis and/or popliteal valve reflux
por: Prandoni, Paolo, et al.
Publicado: (2021)

Model‐informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease
por: Willmann, Stefan, et al.
Publicado: (2022)

Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban‐treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding
por: Kline, Jeffrey A., et al.
Publicado: (2016)

John Moultrie, Jr.
Publicado: (1940)

John Duane, Jr.
Publicado: (1895)

Dr. William Taft. Jr.
Publicado: (1901)

Charles A. Wall, Jr.
Publicado: (1917)

Dr. Franklin Townsend, Jr.
Publicado: (1895)

Dr. John Ashurst, Jr.
Publicado: (1900)

The Edoxaban Hokusai VTE PEDIATRICS Study: An open‐label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease
por: van Ommen, Cornelia Heleen, et al.
Publicado: (2020)

The words of Martin Luther King, Jr.
por: King, Martin Luther, Jr., 1929-1968
Publicado: (2008)

Introducing Edward N. Pugh, Jr.
por: Sparre Andersen, Olaf
Publicado: (2008)

Entrevista a Lanfranco Marcelletti Jr.
por: Gaar, José Antonio
Publicado: (2020)

Obituary: Remembering Michael Piatak, Jr.
por: Lifson, Jeffrey D
Publicado: (2014)

In Memoriam: Louis J. Guillette, Jr.
por: Helbing, Caren C., et al.
Publicado: (2015)

Editorial: Anthony J. Thomas Jr.
Publicado: (2017)

Michael V. Sivak, Jr, MD
Publicado: (2018)

William Shippen, Jr. [1736-1808]
Publicado: (1932)

Dr. Joseph Allen Osmun, Jr.
Publicado: (1917)

Dr. Wm. H. Loughhead, Jr.
Publicado: (1912)

Dr. Robert Barnwell Rhett, Jr.
Publicado: (1901)

In Memoriam; Prof. Wm. Proctor, Jr
Publicado: (1874)

In Memoriam—Martin C. Mihm, Jr.
por: Kupper, Thomas, et al.
Publicado: (2022)

Physiologically Based Pharmacokinetic Modeling of Tamoxifen and its Metabolites in Women of Different CYP2D6 Phenotypes Provides New Insight into the Tamoxifen Mass Balance
por: Dickschen, Kristin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dvjvd5riavm312ido7mu4s0p3d